High plasma free fatty acids increase cardiac UCP3 levels via PPARalpha activation, while UCP2 regulation involves both PPARalpha-dependent and independent pathways in diabetic mouse models.
No takes yet. Share an insight, caveat, or question.
Does not inform clinical practice; extends mechanistic insight into cardiac UCP regulation in diabetic models.
Murray et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: